Dear Dr. {!Match_Record__c.MD_Last_Name__c}, 

The Guardant360 test you ordered to guide treatment selection for your patient {!Match_Record__c.Patient_Last__Name__c} reported {!Match_Record__c.Qualifying_Target_Genes__c} on {!Match_Record__c.Final_Report_Date__c}. We found that this alteration could qualify your patient for the {!Match_Record__c.Trial_Name__c} clinical trial at your institution. 

The Principal Investigator for {!Match_Record__c.Trial_Name__c}, [Principal Investigator Name], and their research staff are included on this email. <b>If you would like to learn more about this trial, please reply to [Principal Investigator Name] ([PI email]) and their team.</b>  

To view the patientâ€™s Guardant360 report in our secure online portal, click the following link: 
{!Match_Record__c.Portal_Link_For_MD_text__c}. 

Sincerely, 
GuardantConnect Global Access Program 
Guardant Health, Inc.

Guardant Health Match Key: {!Match_Record__c.Match_Key__c}

This message is intended solely for the designated recipient(s). It may contain confidential or proprietary information and may be subject to attorney-client privilege or other confidentiality protections. If you are not a designated recipient you may not review, copy or distribute this message. If you have received this in error, please notify the sender by replying to this email and delete this message. Thank you.